Genomics

#Comment #Covid-19 #Genetics #Genomics #Public health #Research

Genomics boosts understanding of Covid-19 severity and susceptibility

Listen to this article on the DDW Podcast: The Covid-19 Host Genetics Initiative carried out one of the largest genome-wide association studies ever. It involved meta-analysis of nearly 50,000 Covid-19 patients and two million uninfected controls. Dr Hamdi Mbarek, Lead Analyst of the Qatari dataset explains how the initiative improved knowledge… Read More

#Covid-19 #Editor's Choice #Exclusive Content #News #Opinion #Trends & Analysis

#Collaboration #Drug development #Drug discovery #Genomics #Machine learning

GSK and Oxford University team up to unravel mechanisms of disease 

GlaxoSmithKline (GSK) and the University of Oxford have announced a five-year collaboration to establish the Oxford-GSK Institute of Molecular and Computational Medicine, which will be based at the University of Oxford and improve the success and speed of research and development of new medicines, building on insights from human… Read More

#News

#Data #Drug development #Drug discovery #Genomics #Research study #Tuberculosis

Largest ever global TB study identifies genetic causes of drug resistance 

The Comprehensive Resistance Prediction for Tuberculosis International Consortium (CRyPTIC) research project has reportedly collected the largest ever global dataset of clinical M. tuberculosis samples from across the world consisting of 15,211 samples from 27 countries on five continents.  Using a new quantitative test for drug resistance and… Read More

#News #Trending News

#Genomics #Immunology / Virology & Vaccines #Research

University researchers develop novel strategy for tuberculosis vaccine 

Researchers at Purdue University and Houston Methodist Research Institute have created a novel strategy for developing an effective vaccine for a widespread form of tuberculosis.  Mycobacterium tuberculosis (Mtb) is a leading cause of death worldwide, leading to over 1.5 million fatalities annually. Approximately one-third of the global… Read More

#News

#AI / data analytics / healthtech / informatics #Genomics #Public health

AWS for Health: accelerating innovation through data access

Dotmatics has announced its support of the AWS for Health initiative from Amazon Web Services (AWS), which aims to improve laboratory efficiency and accelerate the pace of scientific innovation by facilitating more rapid data access, analysis and exchange between scientists worldwide. AWS for Health is an initiative featuring services and… Read More

#News

#Covid-19 #Genomics #Infectious diseases #Therapeutics

Genomics analysis on why Covid-19 affects people so differently

Last year scientists from around the world undertook genetic analysis to uncover the genetic factors influencing why some Covid-19 patients develop severe, life-threatening disease requiring hospitalisation, while others escape with mild symptoms or none at all. A comprehensive summary of their findings to date, published in Nature, reveals 13 loci,… Read More

#Covid-19 #News #Trending News

#Drug discovery #Genetics / genomics #Genomics

Reproducibility in single cell genomic analysis

Listen to this article on the DDW Podcast: By Andrew Gane, Diagnostics Strategy & Technology Manager, Cytiva A cell is a base unit in biology where the genome is transcribed and translated into function. Our traditional understanding of cells rests heavily on studying cells in tissues as an identical population, with… Read More

#Exclusive Content #News

#CRISPR #Genome editing #Genomics

ERS Genomics and Setsuro Tech sign CRISPR/Cas9 license agreement

ERS Genomics and Setsuro Tech have announced a non-exclusive license agreement granting Setsuro Tech access to ERS Genomics’ CRISPR/Cas9 patent portfolio for Japan. Setsuro Tech has developed a high-throughput genome editing method for mammalian embryos, termed genome editing by electroporation of Cas9 protein (GEEP). Using this method, the company is… Read More

#News

#Genetics / genomes #Genomics

IDT launches new CRISPR analysis system

IDT, genomics solutions provider, has launched a new system to provide an end-to-end solution for characterising and quantifying the full array of on and off-target genome editing events in CRISPR research projects, and other genome editing projects. The system uses IDT rhAmpSeq technology, which is designed to enable accurate amplicon… Read More

#News

#Biotechnology #CRISPR #Genomics

ERS Genomics and G+FLAS Life Sciences sign CRISPR/Cas9 license agreement

ERS Genomics and G+FLAS Life Sciences, a biotechnology company developing research tools and reagents associated with CRISPR technology, have announced a non-exclusive license agreement granting G+FLAS access to ERS Genomics’ CRISPR/Cas9 patent portfolio. G+FLAS supports research organisations by providing CRISPR-related biological research services, tools, and reagents. The Ccampany produces all… Read More

#News

#Biotechnology #CRISPR #Genomics #Pharmaceutical #Zebrafish

ERS Genomics and ZeClinics sign CRISPR/Cas9 license agreement

ERS Genomics and ZeClinics have announced a non-exclusive license agreement granting ZeClinics access to ERS Genomics’ CRISPR/Cas9 patent portfolio. ERS Genomics was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier. ZeClinics is a contract research organisation using zebrafish to carry out services… Read More

#News

#Covid-19 #Genomics

US professor calls for better genomic monitoring of COVID-19

The emergence of SARS-CoV-2 virus variants highlight the need for better genomic monitoring of the virus, says Katia Koelle, Associate Professor of Biology at Emory University, Atlanta, Georgia. “Improved genomic surveillance of SARS-CoV-2 across states would really help us to better understand how the virus causing the pandemic is evolving… Read More

#Covid-19 #News #Opinion

#AI / data analytics / healthtech / informatics #Analysis #Animal models #Assay development optimisation & technology #Automation / robotics #Business #Cell therapy #Cellular & Molecular biology #Cellular assays #Chemical engineering #Chemistry #Clinical specialities #Clinical trials #Computational chemistry #Drug development #Drug discovery #Gene therapy #Genomics #High Content Screening #High throughput screening #Immunology / Virology & Vaccines #Lead discovery #Lead optimisation #Mass spectrometry / NMR #Medicinal chemistry #Molecular medicine #Organic chemistry #Pharmokinetics #Precision medicine #RNA #Screening #System biology #Systems biology #Therapeutics #Toxicology

The COVID-19 antiviral race: we’re all in this together

The COVID-19 antiviral race: we're all in this together By Uduak Grace Thomas In response to the COVID-19 pandemic, international scientists from academia and industry have pooled their expertise and resources to identify candidate compounds that inhibit the activity of the SARS-CoV-2 main protease, in order to develop a clinically… Read More

#Covid-19 #Exclusive Content

#Academic #Analysis #Biomarkers #Clinical trials #Drug development #Gene therapy #Genomics #High Content Screening #Therapeutics

The Personalized Medicine Coalition

The Personalized Medicine Coalition The Personalized Medicine Coalition (PMC), representing a broad spectrum of academic, industrial, patient, provider, and payer communities, seeks to advance the understanding and adoption of personalized medicine concepts and products for the benefit of patients. As part of its mission, the PMC publishes The Case for… Read More

#Archive